KAMRI HICKERSON: Open Payments
NPI 1386423531 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$885 in 54 payments from 16 companies in 2025. Trend: 2023 $229 · 2024 $896 · 2025 $885
Food & beverage: $885
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $202 |
| ABBVIE INC. | 14 | $182 |
| Axsome Therapeutics, Inc. | 4 | $93 |
| Lilly USA, LLC | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| PFIZER INC. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| ABIOMED | 1 | $22 |
| Dynavax Technologies Corporation | 1 | $21 |
Products named: VRAYLAR, Rybelsus, Wegovy, JARDIANCE, Symbravo, AIRSUPRA, Veozah, UBRELVY.
Industry payments across TX — which companies pay providers there.
